{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:34:10Z","timestamp":1781278450830,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":2500,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1177\/1087057115569155","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T23:25:38Z","timestamp":1424215538000},"page":"634-645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Repurposing of the Open Access Malaria Box for Kinetoplastid Diseases Identifies Novel Active Scaffolds against Trypanosomatids"],"prefix":"10.1016","volume":"20","author":[{"given":"Marcel","family":"Kaiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leela Pavan","family":"Tadoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Spangenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Robert","family":"Ioset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1177\/1087057115569155_bib1","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1038\/srep04703","article-title":"Nitroheterocyclic Compounds Are More Efficacious Than CYP51 Inhibitors against Trypanosoma Cruzi: Implications for Chagas Disease Drug Discovery and Development","volume":"4","author":"Moraes","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1177\/1087057115569155_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0974-777X.62887","article-title":"Drug Resistance in Leishmaniasis","volume":"2","author":"Chakravarty","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"10.1177\/1087057115569155_bib3","doi-asserted-by":"crossref","first-page":"e709","DOI":"10.1371\/journal.pntd.0000709","article-title":"Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial","volume":"4","author":"Hailu","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1177\/1087057115569155_bib4","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: A Review of Its Pharmacology and Therapeutic Efficacy in the Treatment of Leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1177\/1087057115569155_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/14787210.7.2.157","article-title":"Side Effects of Benznidazole As Treatment in Chronic Chagas Disease: Fears and Realities","volume":"7","author":"Viotti","year":"2009","journal-title":"Exp. Rev. Antiinfect. Ther."},{"key":"10.1177\/1087057115569155_bib6","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1086\/656917","article-title":"Tolerance and Safety of Nifurtimox in Patients with Chronic Chagas Disease","volume":"51","author":"Jackson","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1177\/1087057115569155_bib7","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1086\/429929","article-title":"Effectiveness of a 10-Day Melarsoprol Schedule for the Treatment of Late-Stage Human African Trypanosomiasis: Confirmation From a Multinational Study (IMPAMEL II)","volume":"191","author":"Schmid","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1177\/1087057115569155_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","article-title":"Leishmaniasis: An Update of Current Pharmacotherapy","volume":"14","author":"Sundar","year":"2013","journal-title":"Exp. Opin. Pharmacother."},{"key":"10.1177\/1087057115569155_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1590\/0037-8682-0248-2013","article-title":"The Present Situation, Challenges and Perspectives Regarding the Production and Utilization of Effective Drugs against Human Chagas Disease","volume":"47","author":"Dias","year":"2014","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1177\/1087057115569155_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1017\/S003118201300142X","article-title":"Screening Strategies to Identify New Chemical Diversity for Drug Development to Treat Kinetoplastid Infections","volume":"141","author":"Don","year":"2014","journal-title":"Parasitology"},{"key":"10.1177\/1087057115569155_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of Chemical Starting Points for Antimalarial Lead Identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"10.1177\/1087057115569155_bib12","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.1211936","article-title":"Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery","volume":"334","author":"Meister","year":"2011","journal-title":"Science"},{"key":"10.1177\/1087057115569155_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature09099","article-title":"Chemical Genetics of Plasmodium Falciparum","volume":"465","author":"Guiguemde","year":"2010","journal-title":"Nature"},{"key":"10.1177\/1087057115569155_bib14","doi-asserted-by":"crossref","first-page":"e62906","DOI":"10.1371\/journal.pone.0062906","article-title":"The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases","volume":"8","author":"Spangenberg","year":"2013","journal-title":"PloS One"},{"key":"10.1177\/1087057115569155_bib15","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1128\/AAC.02641-13","article-title":"Identification of Cryptosporidium parvum Active Chemical Series by Repurposing the Open Access Malaria Box","volume":"58","author":"Bessoff","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1177\/1087057115569155_bib16","doi-asserted-by":"crossref","first-page":"e2610","DOI":"10.1371\/journal.pntd.0002610","article-title":"Orally Active Antischistosomal Early Leads Identified from the Open Access Malaria Box","volume":"8","author":"Ingram-Sieber","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1177\/1087057115569155_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jep.2006.04.003","article-title":"Anti-Infective Potential of Natural Products: How to Develop a Stronger in Vitro \u2018Proof-of-Concept.\u2019","volume":"106","author":"Cos","year":"2006","journal-title":"J. Ethnopharmacol."},{"key":"10.1177\/1087057115569155_bib18","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2307\/3282883","article-title":"Continuous Cultivation of Trypanosoma brucei Blood Stream Forms in a Medium Containing a Low Concentration of Serum Protein without Feeder Cell Layers","volume":"75","author":"Hirumi","year":"1989","journal-title":"J. Parasitol."},{"key":"10.1177\/1087057115569155_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(97)00079-X","article-title":"The Alamar Blue Assay to Determine Drug Sensitivity of African Trypanosomes (T. b. Rhodesiense and T. b. Gambiense) In Vitro","volume":"68","author":"Raz","year":"1997","journal-title":"Acta Trop."},{"key":"10.1177\/1087057115569155_bib20","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1128\/AAC.40.11.2592","article-title":"Efficient Technique for Screening Drugs for Activity against Trypanosoma cruzi Using Parasites Expressing Beta-Galactosidase","volume":"40","author":"Buckner","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1177\/1087057115569155_bib21","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1177\/1087057115569155_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and Drug-Like Compounds: The Rule-of-Five Revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Disc. Today Technol."},{"key":"10.1177\/1087057115569155_bib23","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/j.1460-2075.1985.tb03772.x","article-title":"Cultivation in a Semi-Defined Medium of Animal Infective Forms of Trypanosoma brucei, T. equiperdum, T. ervansi, T. rhodesiense and T. gambiense","volume":"4","author":"Baltz","year":"1985","journal-title":"EMBO J."},{"key":"10.1177\/1087057115569155_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0001-706X(93)90083-N","article-title":"A Comparison of 3 Methods of Estimating Ec(50) in Studies of Drug-Resistance of Malaria Parasites","volume":"55","author":"Huber","year":"1993","journal-title":"Acta Trop."},{"key":"10.1177\/1087057115569155_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2009.01819.x","article-title":"Use of Isothermal Microcalorimetry to Monitor Microbial Activities","volume":"303","author":"Braissant","year":"2010","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1177\/1087057115569155_bib26","doi-asserted-by":"crossref","first-page":"e1668","DOI":"10.1371\/journal.pntd.0001668","article-title":"Isothermal Microcalorimetry, a New Tool to Monitor Drug Action against Trypanosoma brucei and Plasmodium falciparum","volume":"6","author":"Wenzler","year":"2012","journal-title":"PloS Negl. Trop. Dis."},{"key":"10.1177\/1087057115569155_bib27","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1128\/AAC.00398-13","article-title":"Pharmacokinetics, Trypanosoma brucei gambiense Efficacy, and Time of Drug Action of DB829, a Preclinical Candidate for Treatment of Second-Stage Human African Trypanosomiasis","volume":"57","author":"Wenzler","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1177\/1087057115569155_bib28","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1016\/j.bmc.2003.08.012","article-title":"2,4-Diaminopyrimidines as inhibitors of Leishmanial and Trypanosomal dihydrofolate reductase","volume":"3","author":"Pez","year":"2003","journal-title":"Bioorgan. Med. Chem."},{"key":"10.1177\/1087057115569155_bib29","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/j.bmc.2005.01.025","article-title":"Design, Synthesis and Evaluation of 2,4-Diaminoquinazolines as Inhibitors of Trypanosomal and Leishmanial Dihydrofolate Reductase","volume":"1","author":"Khabnadideh","year":"2005","journal-title":"Bioorgan. Med. Chem."},{"key":"10.1177\/1087057115569155_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.molbiopara.2013.02.008","article-title":"Folate Metabolism in Human Malaria Parasites\u201475 Years on","volume":"188","author":"M\u00fcller","year":"2013","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1177\/1087057115569155_bib31","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1021\/ml400015f","article-title":"Identification and Optimization of an Aminoalcohol-Carbazole Series with Antimalarial Properties","volume":"22","author":"Molette","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1177\/1087057115569155_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1042\/bj2860009","article-title":"Rationally Designed Selective Inhibitors of Trypanothione Reductase: Phenothiazines and Related Tricyclics as Lead Structures","volume":"15","author":"Benson","year":"1992","journal-title":"Biochem. J."},{"key":"10.1177\/1087057115569155_bib33","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2174\/1389450111009011614","article-title":"Targeting Trypanothione Metabolism in Trypanosomatid Human Parasites","volume":"11","author":"Olin-Sandoval","year":"2010","journal-title":"Curr. Drug Targets."},{"key":"10.1177\/1087057115569155_bib34","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1128\/AAC.01568-08","article-title":"Trypanothione Reductase High-Throughput Screening Campaign Identifies Novel Classes of Inhibitors with Antiparasitic Activity","volume":"53","author":"Holloway","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1177\/1087057115569155_bib35","doi-asserted-by":"crossref","first-page":"e1736","DOI":"10.1371\/journal.pntd.0001736","article-title":"Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51","volume":"6","author":"Gunatilleke","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1177\/1087057115569155_bib36","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nrd3287","article-title":"The Effect of Plasma Protein Binding on In Vivo Efficacy: Misconceptions in Drug Discovery","volume":"9","author":"Smith","year":"2010","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1087057115569155","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1087057115569155","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555222072318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555222072318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1087057115569155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T11:41:08Z","timestamp":1762861268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555222072318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S2472555222072318"],"URL":"https:\/\/doi.org\/10.1177\/1087057115569155","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing of the Open Access Malaria Box for Kinetoplastid Diseases Identifies Novel Active Scaffolds against Trypanosomatids","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1177\/1087057115569155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Society for Laboratory Automation and Screening. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}